Results 51 to 60 of about 10,837 (204)

Effects of Pallidal Deep Brain Stimulation on Speech and Swallowing in Pediatric Patients with Dystonia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Bilateral globus pallidus internus deep brain stimulation (GPi‐DBS) is a proven safe and effective treatment in certain forms of idiopathic or inherited dystonia (ID/IN). Its effects in acquired dystonia such as in dyskinetic cerebral palsy (DCP) however vary widely.
Katerina Bernardi, Andrea A. Kühn, Ana Luísa de Almeida Marcelino, Matthias Eckenweiler, Cornelia Rensing‐Zimmermann, Joachim K. Krauss, Joachim Runge, Rene Marquez Franco, Delia Lorenz, Monika Müller, Alfons Schnitzler, Andrea Bevot, Lidwin von Spee, Veerle Visser‐Vandewalle, Lars Timmermann, Petra Schiller, Anne Koy   +16 more
wiley   +1 more source

Tic Disorder: An Unusual Presentation of Neurotoxoplasmosis in a Patient with AIDS

Case Reports in Neurology, 2010
Movement disorders have been increasingly recognized in patients with HIV infection and may be due to distinct causes, as opportunistic infections or medication side effects for example. Parkinsonism, tremor and hemichorea have been more frequently noted
Camila Catherine Henriques Aquino, André Carvalho Felício, Clecio Godeiro-Junior, Denizart Santos-Neto, JoséLuiz Pedroso, Acary Souza Bulle Oliveira, Sônia Maria Azevedo Silva, Vanderci Borges, Henrique Ballalai Ferraz   +8 more
doaj   +1 more source

The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan, Seyed‐Mohammad Fereshtehnejad, Christos Ganos, Emily Swinkin, Anthony E. Lang   +4 more
wiley   +1 more source

Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA

Toxins
The therapeutic efficacy remaining from prior treatments with botulinum toxins (BoNTs) when cervical dystonia (CD) patients prefer to be re-treated has not been well characterized. Here, we assessed the residual therapeutic efficacy of BoNT injections at
Aaron Ellenbogen, Robert A. Hauser, Atul T. Patel, Peter McAllister, Todd M. Gross, Rashid Kazerooni, Conor J. Gallagher, David A. Hollander   +7 more
doaj   +1 more source

Botulinum-A toxin in the treatment of painful post-stroke nocturnal paroxysmal dystonia triggered by periodic limb movements of sleep: case report Toxina botulínica tipo A no tratamento da distonia paroxística noturna dolorosa pós-isquemia cerebral desencadeada por movimentos periódicos do sono: relato de caso

Arquivos de Neuro-Psiquiatria, 2006
INTRODUCTION: Sleep disorders presenting involuntary movements may be very annoying to patients, apart from their negative influence on sleep. OBJECTIVE: To report the use of botulinum type-A toxin (BoNT-A) to manage the case of a patient whose sleep was
Pedro A. Kowacs, Hélio A. Ghizoni Teive, Elcio J. Piovesan, Jorge A. Zavala, Lineu C. Werneck   +4 more
doaj   +1 more source

Role of a wireless surface electromyography in dystonic gait in functional movement disorders: A case report

World Journal of Clinical Cases, 2020
Dystonic gait (DG) is one of clinical symptoms associated with functional dystonia in the functional movement disorders (FMDs). Dystonia is often initiated or worsened by voluntary action and associated with overflow muscle activation. There is no report for DG in FMDs caused by an abnormal pattern in the ankle muscle recruitment strategy during gait.A
Oh, Min-Kyun, Kim, Hyeong Seop, Jang, Yun Jeong, Lee, Chang Han   +3 more
openaire   +2 more sources

Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information

Toxins
The first-line management of cervical dystonia (CD) symptoms is intramuscular injection of botulinum toxin type A (BoNTA). However, a comparison of safety among BoNTAs is difficult because, per regulatory authorities, units of BoNTA activity are not ...
Khashayar Dashtipour, Han S. Lee, Aaron Ellenbogen, Rashid Kazerooni, Todd M. Gross, David A. Hollander, Conor J. Gallagher   +6 more
doaj   +1 more source

Doenças do movimento induzidas por fármacos: a importância dos psicofármacos.

Acta Médica Portuguesa, 2011
This article reviews the current knowledge on drug-induced movement disorders (DIMD) epidemiology, pathophysiology, phenomenology and treatment. This review is justified by its high prevalence in certain medical specialties, the need to include them on ...
Joana Damásio, Serafim Carvalho
doaj   +1 more source

Tardive Dystonia: Clinical Spectrum and Novel Manifestations

Behavioural Neurology, 1988
Tardive dystonia was identified in 25 patients: involvement of the face and neck was most common; truncal and limb dystonia were also observed. There were 3 cases of laryngospasm and 2 of spasmodic dysphonia.
R. Jeffrey Davis, Jeffrey L. Cummings, Robert W. Hierholzer   +2 more
doaj   +1 more source

Efficacy of Segmental Muscle Vibration on Pain Modulation in Patients with Primary Cervical Dystonia Treated with Botulinum Type-A Toxin: A Protocol for a Randomized Controlled Trial

NeuroSci
Primary cervical dystonia (PCD), or spasmodic torticollis, is a focal dystonia characterized by involuntary and often painful muscle contractions, leading to abnormal cervical movements and postures.
Riccardo Buraschi, Paolo Pedersini, Giacomo Redegalli, Rosa Pullara, Joel Pollet, Marina Rossi, Massimiliano Gobbo, Sara Gueli, Maurizio Falso   +8 more
doaj   +1 more source